Results 201 to 210 of about 658,704 (259)
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source
Evidence-based AI: from trailblazer to trustblazer? [PDF]
Luechtefeld T, Hartung T.
europepmc +1 more source
PROTOCOL: Life Skills Education and Psychosocial Interventions for Anxiety and Depression in Forcibly Displaced Persons in LMICs: A Systematic Review. [PDF]
Duke AEE +5 more
europepmc +1 more source
Additional Considerations in Pediatric Clavicle Fracture Non-Union: An Under-Recognized Clinical Entity. [PDF]
Qureshi NA.
europepmc +1 more source

